Olmesartan Genericon (Olmesartan Medoxomil)

Olmesartan medoxil, the active ingredient in Olmesartan Genericon, is an angiotensin II receptor blocker presented as a tablet for oral use. It is employed in the management of hypertension in adult patients. GNH USA supplies Olmesartan Genericon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Genericon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan Genericon is an angiotensin II receptor blocker indicated for conditions affecting the renin‑angiotensin system.

- Hypertension: lowers elevated blood pressure and reduces cardiovascular risk. - Diabetic nephropathy: slows progression of kidney damage associated with type 2 diabetes. - Heart failure: used as part of combination therapy to improve symptoms and outcomes.

Adverse reactions to olmesartan may vary in frequency and severity.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea - Cough

Serious or Rare Side Effects: - Angio‑edema - Severe hypotension - Acute kidney injury - Hyperkalemia - Liver enzyme elevation - Myocardial infarction

Olmesartan Genericon should be used with caution in specific clinical situations.

- Monitor: regular blood pressure and renal function assessments. - Adjust: dose may need modification in patients with hepatic impairment. - Avoid: concurrent use with aliskiren in patients with diabetes. - Contraindicated: known reactions to any angiotensin‑II receptor blockers. - Pregnancy: t    t    \n Store  ​   t ​   t  \